LYRICA® vs. Gabapentin

 
# LPD Pregabalin-Lyrica-IND-English version : 22.0.
 
References:
  1. Lyrica Local LPD-LPDLYC012021.
  2. Neurontin USPI-Revised: 12/2020.
Please click on Prescribing Information link to view safety and adverse events information of LYRICA®.
For the use only of registered medical practitioners or a hospital or a laboratory.
 
# LPD Pregabalin-Lyrica-IND-English version : 22.0.
 
References:
  1. Lyrica Local LPD-LPDLYC012021.
  2. Neurontin USPI-Revised: 12/2020.
Please click on Prescribing Information link to view safety and adverse events information of LYRICA®.
For the use only of registered medical practitioners or a hospital or a laboratory.
 
# LPD Pregabalin-Lyrica-IND-English version : 22.0.
 
References:
  1. Lyrica Local LPD-LPDLYC012021.
  2. Neurontin USPI-Revised: 12/2020.
Please click on Prescribing Information link to view safety and adverse events information of LYRICA®.
For the use only of registered medical practitioners or a hospital or a laboratory.
 
# LPD Pregabalin-Lyrica-IND-English version : 22.0.
 
References:
  1. Lyrica Local LPD-LPDLYC012021.
  2. Neurontin USPI-Revised: 12/2020.
  3. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clinical pharmacokinetics. 2010 Oct;49(10):661-9.
Please click on Prescribing Information link to view safety and adverse events information of LYRICA®.
For the use only of registered medical practitioners or a hospital or a laboratory.
 
# LPD Pregabalin-Lyrica-IND-English version : 22.0.
 
References:
  1. Lyrica Local LPD-LPDLYC012021.
  2. Neurontin USPI-Revised: 12/2020.
Please click on Prescribing Information link to view safety and adverse events information of LYRICA®.
For the use only of registered medical practitioners or a hospital or a laboratory.

PP-LYR-IND-0225 dated 14th July, 2021